GlassScriptPhysician profile
Analiz Rodriguez
NPI 1952613960
$12,620.77
in general payments reported to CMS, 2019-2025
7 companies · $541 in 2025
The $541 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,312 · 2023: $4,900 · 2024: $867 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,019 · Food and Beverage: $1,790 · Honoraria: $1,000 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,018.62 |
| Food and Beverage | $1,789.98 |
| Honoraria | $1,000.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nico Corporation | $4,716.81 | 2022-2023 | |
| Medexus Pharma, INC. | $4,385.17 | 2022-2023 | Gleolan |
| Brainlab, INC. | $1,456.37 | 2023 | Image Guided Surgical Device |
| Monteris Medical Corporation | $1,348.68 | 2022-2024 | Neuroblate |
| Gt Medical Technologies, INC | $459.41 | 2022-2025 | Gammatile |
| Medtronic, INC. | $149.68 | 2025 | Stealthstation S8 Platform |
| Omniscient Neurotechnology America LTD | $104.65 | 2023 | Quicktome |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Analiz Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.